Aspetti Farmacoeconomici dei farmaci Inibitori del Checkpoint Immunitario (ICI)

Personalized medicine represents a notable advance in medical practice, as it allows treatments to be adapted to the genetic and phenotypic characteristics of patients. This approach is particularly consolidated in oncology, where it has revolutionized clinical practice. Personalizing treatment base...

Ausführliche Beschreibung

Bibliographische Detailangaben

Format:	Online
Sprache:	Italienisch
Veröffentlicht:	FedOA - Federico II University Press 2024
Schlagworte:	Pharmacoeconomics, Inhibiting Drugs of the Immune Checkpoint, Pharmacoutilization thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
Online-Zugang:	https://directory.doabooks.org/handle/20.500.12854/142754
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!